Home > Insider Trading > Filing (0001209191-13-036101)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
875320	Vertex Pharmaceuticals Inc / Ma	VRTX	Pharmaceutical Preparations (2834)	043039129

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1552047	L Kenneth Horton	C/O Vertex Pharmaceuticals Incorporated 130 Waverly St. Cambridge MA 02139	Evp & Chief Legal Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2013-07-08	1,513	$80.50	20,976	No	4	S	Direct
Common Stock	Disposition	2013-07-08	300	$81.82	20,676	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	366	Indirect	401(k)

Footnotes

Transaction made pursuant to Mr. Horton's company approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $80.50 (range $80.17 to $80.84).
Mr. Horton undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $81.82 (range $81.61 to $82.19).